US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VistaGen Therapeutics

0.3078

+0.00983.29%

Post-market: 0.2950-0.0128-4.16%19:55 EDT

Volume:2.43M

Turnover:739.77K

Market Cap:13.66M

PE:-0.19

High:0.3180

Open:0.2896

Low:0.2840

Close:0.2980

52wk High:5.14

52wk Low:0.1980

Shares:44.38M

Float Shares:41.42M

Volume Ratio:0.02

T/O Rate:5.86%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6559

EPS(LYR):-1.8303

ROE:-166.46%

ROA:-83.21%

PB:0.56

PE(LYR):-0.17

Loading ...

Overview Company News Filings

VistaGen appoints Angel Angelov as chief medical officer

Vistagen Appoints Angel S. Angelov, Md, MBA, as Chief Medical Officer

THOMSON REUTERS

VistaGen reports positive fasedienol data in PALISADE-3 open-label extension study

Vistagen Therapeutics Inc - Palisade-4 Topline Data Expected in Q2 2026

THOMSON REUTERS

Vistagen Therapeutics Inc - Fasedienol Nasal Spray Well-Tolerated With No New Safety Findings After 12 Months

THOMSON REUTERS

Vistagen Therapeutics Inc - No Serious Adverse Events Related to Fasedienol Reported

THOMSON REUTERS

Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of Palisade-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prime Medicine, Inc. (PRME)

BRIEF-Vistagen Announces Completion Of Last Patient Visit In Palisade-4 Phase 3 Public Speaking Challenge Study Of Fasedienol For Acute Treatment Of Social Anxiety Disorder

VistaGen completes last patient visit in PALISADE-4 Phase 3 fasedienol trial

Vistagen Therapeutics Inc - Open Label Extension of Palisade-4 Study Remains Ongoing

THOMSON REUTERS

Vistagen Therapeutics Inc - Topline Results for Palisade-4 Randomized Portion Expected in Q2 2026

THOMSON REUTERS

VistaGen says FDA clears refisolone IND to proceed with Phase 2 studies

AbCellera target is profile more attractive than Vistagen, says JonesResearch

VistaGen says FDA clears Phase 2 refisolone study for menopausal hot flashes

Vistagen Receives FDA “Study May Proceed” Letter Under Its Refisolone Ind Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) Due to Menopause

THOMSON REUTERS

Vistagen Therapeutics Inc - FDA Letter Enables Further Phase 2 Development of Refisolone in the U.S.

THOMSON REUTERS

VistaGen Therapeutics Grants Broad Employee Retention Stock Options

VistaGen grants retention stock options to executives at $0.54 per share

VistaGen flags Nasdaq noncompliance after audit committee falls below three members

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/VTGN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":0.3078,"timestamp":1790798400000,"preClose":0.298,"halted":0,"volume":2427156,"hourTrading":{"tag":"盘后","latestPrice":0.295,"preClose":0.3078,"latestTime":"19:55 EDT","volume":51736,"amount":15379.491847,"timestamp":1790812502822,"change":-0.0128,"changeRate":-0.041585,"amplitude":0.041585},"delay":0,"changeRate":0.03288590604026856,"floatShares":41422900,"shares":44376899,"eps":-1.655879,"marketStatus":"Not Yet Opened","change":0.0098,"latestTime":"09-30 16:00:00 EDT","open":0.2896,"high":0.318,"low":0.284,"amount":739766.8578931199,"amplitude":0.114094,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.655879,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":0.298,"preHourTrading":{"tag":"盘前","latestPrice":0.286,"preClose":0.298,"latestTime":"09:28 EDT","volume":143270,"amount":41029.4305026,"timestamp":1790774929547,"change":-0.012,"changeRate":-0.040268,"amplitude":0.102349},"postHourTrading":{"tag":"盘后","latestPrice":0.295,"preClose":0.3078,"latestTime":"19:55 EDT","volume":51736,"amount":15379.491847,"timestamp":1790812502822,"change":-0.0128,"changeRate":-0.041585,"amplitude":0.041585},"volumeRatio":0.019925,"impliedVol":3.512,"impliedVolPercentile":0.9084},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":41422900,"roa":"-83.21%","roe":"-166.46%","lyrEps":-1.830255,"volumeRatio":0.019925,"shares":44376899,"dividePrice":0,"high":0.318,"amplitude":0.114094,"preClose":0.298,"low":0.284,"week52Low":0.198,"pbRate":"0.56","psRate":"5.46","week52High":5.14,"institutionHeld":0,"latestPrice":0.3078,"eps":-1.655879,"divideRate":0,"volume":2427156,"delay":0,"ttmEps":-1.655879,"open":0.2896,"prevYearClose":0.6619,"prevWeekClose":0.273,"prevMonthClose":0.255,"prevQuarterClose":0.226,"fiveDayClose":0.3684,"twentyDayClose":0.2433,"sixtyDayClose":0.2369},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"VTGN","fiscalQuarterEnding":"2026/06","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-06-15","symbol":"VTGN","fiscalQuarterEnding":"2026/03","expectedEps":-0.42,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1781496000000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2026-02-12","symbol":"VTGN","fiscalQuarterEnding":"2025/12","expectedEps":-0.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-11-13","symbol":"VTGN","fiscalQuarterEnding":"2025/09","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2025-08-07","symbol":"VTGN","fiscalQuarterEnding":"2025/06","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.47}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1766030400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2026-09-29","current":-0.185883,"percent":0.95106,"low":-23.608421,"twenty":-3.921816,"median":-1.665762,"eighty":-0.420606,"high":-0.133075,"avg":-2.934811,"sd":4.001022,"marketCap":13179942},"quantilePoints":[{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515},{"date":"2025-04-25","current":-1.427729,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":67537278},{"date":"2025-05-02","current":-1.439932,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68114520},{"date":"2025-05-09","current":-1.372816,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":64939691},{"date":"2025-05-16","current":-1.403323,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66382795},{"date":"2025-05-23","current":-1.482641,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":70134866},{"date":"2025-05-30","current":-1.555858,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":73598316},{"date":"2025-06-06","current":-1.446033,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":68403141},{"date":"2025-06-13","current":-1.412475,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":66815726},{"date":"2025-06-20","current":-1.168169,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":60064929},{"date":"2025-06-27","current":-1.162499,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":59773352},{"date":"2025-07-03","current":-1.134145,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":58315466},{"date":"2025-07-11","current":-1.377986,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":70853291},{"date":"2025-07-18","current":-1.440364,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":74060641},{"date":"2025-07-25","current":-1.536766,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":79017456},{"date":"2025-08-01","current":-1.627498,"twenty":-11.864307,"median":-2.929666,"eighty":-0.737322,"marketCap":83682693},{"date":"2025-08-08","current":-1.585392,"twenty":-11.864307,"median":-2.927982,"eighty":-0.737322,"marketCap":81517693},{"date":"2025-08-15","current":-1.625328,"twenty":-11.864307,"median":-2.915434,"eighty":-0.737322,"marketCap":90660791},{"date":"2025-08-22","current":-1.683081,"twenty":-11.864307,"median":-2.877336,"eighty":-0.737322,"marketCap":93882241},{"date":"2025-08-29","current":-1.776585,"twenty":-11.864307,"median":-2.863852,"eighty":-0.737322,"marketCap":99097921},{"date":"2025-09-05","current":-1.991095,"twenty":-11.876769,"median":-2.857435,"eighty":-0.736288,"marketCap":111063305},{"date":"2025-09-12","current":-1.925092,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":107381648},{"date":"2025-09-19","current":-1.67208,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":93268631},{"date":"2025-09-26","current":-1.853589,"twenty":-11.864307,"median":-2.851018,"eighty":-0.737322,"marketCap":103393187},{"date":"2025-10-03","current":-1.980095,"twenty":-11.864307,"median":-2.83596,"eighty":-0.737322,"marketCap":110449695},{"date":"2025-10-10","current":-2.315611,"twenty":-11.864307,"median":-2.802915,"eighty":-0.737322,"marketCap":129164782},{"date":"2025-10-17","current":-2.227607,"twenty":-11.864307,"median":-2.73437,"eighty":-0.737322,"marketCap":124255907},{"date":"2025-10-24","current":-2.28811,"twenty":-11.864307,"median":-2.673112,"eighty":-0.737322,"marketCap":127630759},{"date":"2025-10-31","current":-2.062599,"twenty":-11.864307,"median":-2.649105,"eighty":-0.737322,"marketCap":115051766},{"date":"2025-11-07","current":-2.211106,"twenty":-11.864307,"median":-2.567594,"eighty":-0.737322,"marketCap":123335493},{"date":"2025-11-14","current":-2.0901,"twenty":-11.864307,"median":-2.53499,"eighty":-0.737322,"marketCap":116585789},{"date":"2025-11-21","current":-2.824005,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":175754756},{"date":"2025-11-28","current":-3.109578,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":193527709},{"date":"2025-12-05","current":-2.716121,"twenty":-11.864307,"median":-2.526839,"eighty":-0.737322,"marketCap":169040530},{"date":"2025-12-12","current":-2.506701,"twenty":-11.864307,"median":-2.518688,"eighty":-0.737322,"marketCap":156007031},{"date":"2025-12-19","current":-0.46961,"twenty":-11.801994,"median":-2.505871,"eighty":-0.722332,"marketCap":29226633},{"date":"2025-12-26","current":-0.461931,"twenty":-11.590132,"median":-2.494234,"eighty":-0.710167,"marketCap":28748738},{"date":"2026-01-02","current":-0.420047,"twenty":-11.390732,"median":-2.469781,"eighty":-0.68148,"marketCap":26142039},{"date":"2026-01-09","current":-0.446637,"twenty":-11.216257,"median":-2.464118,"eighty":-0.673408,"marketCap":27796898},{"date":"2026-01-16","current":-0.425822,"twenty":-10.967006,"median":-2.453479,"eighty":-0.659291,"marketCap":26501447},{"date":"2026-01-23","current":-0.420555,"twenty":-10.431119,"median":-2.445328,"eighty":-0.65328,"marketCap":26173635},{"date":"2026-01-30","current":-0.34345,"twenty":-10.119556,"median":-2.404572,"eighty":-0.642171,"marketCap":21374938},{"date":"2026-02-06","current":-0.320477,"twenty":-9.795531,"median":-2.350491,"eighty":-0.624554,"marketCap":19945202},{"date":"2026-02-13","current":-0.345861,"twenty":-9.421655,"median":-2.315611,"eighty":-0.614743,"marketCap":21525020},{"date":"2026-02-20","current":-0.350015,"twenty":-9.12284,"median":-2.255108,"eighty":-0.605072,"marketCap":23467113},{"date":"2026-02-27","current":-0.35752,"twenty":-8.530345,"median":-2.227607,"eighty":-0.589095,"marketCap":23970291},{"date":"2026-03-06","current":-0.363016,"twenty":-8.242307,"median":-2.211106,"eighty":-0.576686,"marketCap":24338760},{"date":"2026-03-13","current":-0.372766,"twenty":-7.777016,"median":-2.194605,"eighty":-0.562871,"marketCap":24992495},{"date":"2026-03-20","current":-0.379562,"twenty":-7.699467,"median":-2.167104,"eighty":-0.554569,"marketCap":25448129},{"date":"2026-03-27","current":-0.357402,"twenty":-7.533291,"median":-2.132332,"eighty":-0.544676,"marketCap":23962367},{"date":"2026-04-02","current":-0.35492,"twenty":-7.333881,"median":-2.090107,"eighty":-0.536314,"marketCap":23795962},{"date":"2026-04-10","current":-0.328505,"twenty":-7.090157,"median":-2.076032,"eighty":-0.525611,"marketCap":22024934},{"date":"2026-04-17","current":-0.356397,"twenty":-7.034765,"median":-2.061958,"eighty":-0.517151,"marketCap":23895013},{"date":"2026-04-24","current":-0.336837,"twenty":-6.835354,"median":-2.029597,"eighty":-0.503917,"marketCap":22583580},{"date":"2026-05-01","current":-0.362484,"twenty":-6.724571,"median":-2.012696,"eighty":-0.497346,"marketCap":24303102},{"date":"2026-05-08","current":-0.346765,"twenty":-6.59163,"median":-1.998621,"eighty":-0.492227,"marketCap":23249202},{"date":"2026-05-15","current":-0.384467,"twenty":-6.536238,"median":-1.977509,"eighty":-0.489403,"marketCap":25776978},{"date":"2026-05-22","current":-0.376489,"twenty":-6.370063,"median":-1.952594,"eighty":-0.486511,"marketCap":25242103},{"date":"2026-05-29","current":-0.374244,"twenty":-6.314671,"median":-1.938843,"eighty":-0.483895,"marketCap":25091546},{"date":"2026-06-05","current":-0.340146,"twenty":-6.093103,"median":-1.917691,"eighty":-0.479626,"marketCap":22805454},{"date":"2026-06-12","current":-0.338669,"twenty":-5.871536,"median":-1.900098,"eighty":-0.476614,"marketCap":22706403},{"date":"2026-06-18","current":-0.40775,"twenty":-5.672125,"median":-1.865443,"eighty":-0.47471,"marketCap":27338018},{"date":"2026-06-26","current":-0.363071,"twenty":-5.376,"median":-1.830656,"eighty":-0.471134,"marketCap":25300610},{"date":"2026-07-02","current":-0.143085,"twenty":-4.842874,"median":-1.826119,"eighty":-0.469733,"marketCap":9970886},{"date":"2026-07-10","current":-0.146736,"twenty":-4.539092,"median":-1.813883,"eighty":-0.464279,"marketCap":10225287},{"date":"2026-07-17","current":-0.141319,"twenty":-4.458187,"median":-1.805014,"eighty":-0.46145,"marketCap":9847788},{"date":"2026-07-24","current":-0.133075,"twenty":-4.33683,"median":-1.789237,"eighty":-0.459098,"marketCap":9273334},{"date":"2026-07-31","current":-0.141907,"twenty":-4.25542,"median":-1.781367,"eighty":-0.456852,"marketCap":9888821},{"date":"2026-08-07","current":-0.167109,"twenty":-4.162313,"median":-1.766387,"eighty":-0.453483,"marketCap":11645010},{"date":"2026-08-14","current":-0.156805,"twenty":-4.146212,"median":-1.758762,"eighty":-0.447316,"marketCap":10926942},{"date":"2026-08-21","current":-0.146302,"twenty":-4.084003,"median":-1.745275,"eighty":-0.445377,"marketCap":9892924},{"date":"2026-08-28","current":-0.168661,"twenty":-4.029034,"median":-1.735242,"eighty":-0.435916,"marketCap":11404866},{"date":"2026-09-04","current":-0.161573,"twenty":-4.010489,"median":-1.710088,"eighty":-0.433015,"marketCap":10925595},{"date":"2026-09-11","current":-0.156848,"twenty":-4.001412,"median":-1.702292,"eighty":-0.430922,"marketCap":10606081},{"date":"2026-09-18","current":-0.153304,"twenty":-3.959374,"median":-1.684041,"eighty":-0.428121,"marketCap":10366446},{"date":"2026-09-25","current":-0.193599,"twenty":-3.926313,"median":-1.671017,"eighty":-0.420877,"marketCap":13091188},{"date":"2026-09-29","current":-0.194912,"twenty":-3.921816,"median":-1.665762,"eighty":-0.420606,"marketCap":13179942}],"updateTime":1790817887487},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636410856","title":"VistaGen appoints Angel Angelov as chief medical officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636410856","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636410856?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:30","pubTimestamp":1779193845,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics appointed Angel S. Angelov as chief medical officer, effective May 18, 2026.Angelov most recently served as chief medical officer at Theranica, a neuromodulation therapeutics company.He previously held senior clinical development or medical affairs roles at Karuna Therapeutics, Neurocrine Biosciences, Novartis, and Teva.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 19, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nNDL5mPJj7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1261432733.SGD","LU1883839398.USD","LU1074936037.SGD","BMY","LU0114720955.EUR","LU0321505439.SGD","LU0320765992.SGD","LU2065171402.SGD","LU1670711123.USD","LU2242646821.SGD","LU1868836591.USD","LU0225771236.USD","VTGN","BK4007","LU0154245756.USD","LU0985481810.HKD","LU1718418525.SGD","NBIX","BK4559","LU0109394709.USD","LU1585245621.USD","LU1571399168.USD","LU2065169927.USD","LU2065170008.USD","LU0823416689.USD","LU2360032135.SGD","LU2324357040.USD","IE0009355771.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU1032466523.USD","LU2065171311.SGD","LU1323610961.USD","LU0096364046.USD","LU0061475181.USD","LU1868836914.USD","LU1983299246.USD","BK4585","LU1093756325.SGD","LU1670710661.SGD","LU0456855351.SGD","IE00BSNM7G36.USD","LU2125154935.USD","IE0002141913.USD","LU1868836757.USD","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1670711040.USD","LU1670710588.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636856288","title":"Vistagen Appoints Angel S. Angelov, Md, MBA, as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2636856288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636856288?lang=en_us&edition=fundamental","pubTime":"2026-05-19 20:30","pubTimestamp":1779193801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nTUABCPQFP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634647215","title":"VistaGen reports positive fasedienol data in PALISADE-3 open-label extension study","url":"https://stock-news.laohu8.com/highlight/detail?id=2634647215","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634647215?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585445,"startTime":"0","endTime":"0","summary":"VistaGen reported preliminary positive data already released from ongoing open-label extension of PALISADE-3 Phase 3 study of fasedienol nasal spray for acute treatment of social anxiety disorder.Interim readout showed fasedienol remained generally well tolerated with no new drug-related safety issues during as-needed use in daily life for up to 12 months.Exploratory assessments indicated social anxiety symptoms eased over time across clinician-rated and patient-reported measures during first four months of treatment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL7FFBTN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215682","title":"Vistagen Therapeutics Inc - Palisade-4 Topline Data Expected in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215682?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA33ZTTW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215634","title":"Vistagen Therapeutics Inc - Fasedienol Nasal Spray Well-Tolerated With No New Safety Findings After 12 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215634?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA33ZTTW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215501","title":"Vistagen Therapeutics Inc - No Serious Adverse Events Related to Fasedienol Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215501?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA33ZTTW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634156842","title":"Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of Palisade-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2634156842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634156842?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA33ZTTW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634292469","title":"Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prime Medicine, Inc. (PRME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634292469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634292469?lang=en_us&edition=fundamental","pubTime":"2026-05-09 02:50","pubTimestamp":1778266245,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tenaya Therapeutics (TNYA), VistaGen Therapeutics (VTGN) and Prim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-vistagen-therapeutics-vtgn-and-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-vistagen-therapeutics-vtgn-and-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4585","VTGN","BK4139","BK4588","XBI","XLV","BK4137","TNYA","LU0029874061.USD","BK4581","BK4539","HCSG","PRME","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633340453","title":"BRIEF-Vistagen Announces Completion Of Last Patient Visit In Palisade-4 Phase 3 Public Speaking Challenge Study Of Fasedienol For Acute Treatment Of Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2633340453","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633340453?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239851,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen Announces Completion Of Last Patient Visit In Palisade-4 Phase 3 Public Speaking Challenge Study Of Fasedienol For Acute Treatment Of Social Anxiety DisorderMay 8 (Reuters) - VistaGen T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA9RHLTK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453347","title":"VistaGen completes last patient visit in PALISADE-4 Phase 3 fasedienol trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453347","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453347?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239822,"startTime":"0","endTime":"0","summary":"VistaGen completed last patient last visit in randomized, double-blind, placebo-controlled portion of PALISADE-4 Phase 3 study of fasedienol nasal spray for acute treatment of social anxiety disorder.Topline results have not been presented yet; release expected this quarter.Trial is designed to assess whether a single dose can reduce anxiety symptoms during a simulated public speaking challenge, with safety and tolerability also evaluated.Company refined primary efficacy analysis to account for participants’ distress level immediately before dosing; FDA indicated it had no comments on the change.Open-label extension remains ongoing, allowing continued use in daily life for up to 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL7h8mQG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633945338","title":"Vistagen Therapeutics Inc - Open Label Extension of Palisade-4 Study Remains Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633945338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633945338?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA9RHLTK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633533384","title":"Vistagen Therapeutics Inc - Topline Results for Palisade-4 Randomized Portion Expected in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633533384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633533384?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:30","pubTimestamp":1778239800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA9RHLTK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631364505","title":"VistaGen says FDA clears refisolone IND to proceed with Phase 2 studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2631364505","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631364505?lang=en_us&edition=fundamental","pubTime":"2026-04-29 04:38","pubTimestamp":1777408721,"startTime":"0","endTime":"0","summary":"VistaGen received an FDA “Study May Proceed” letter under its IND for refisolone nasal spray, clearing further Phase 2 development in the US for menopausal hot flashes.Refisolone is positioned as a non-hormonal, non-systemic treatment targeting moderate to severe vasomotor symptoms due to menopause.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL9cgmnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629028466","title":"AbCellera target is profile more attractive than Vistagen, says JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2629028466","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629028466?lang=en_us&edition=fundamental","pubTime":"2026-04-22 22:45","pubTimestamp":1776869136,"startTime":"0","endTime":"0","summary":"JonesResearch notes that Vistagen (VTGN) received an FDA “Study May Proceed” letter enabling further Phase 2 development of intranasal refisolone f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-target-is-profile-more-attractive-than-vistagen-says-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-target-is-profile-more-attractive-than-vistagen-says-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","LABU","VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629495540","title":"VistaGen says FDA clears Phase 2 refisolone study for menopausal hot flashes","url":"https://stock-news.laohu8.com/highlight/detail?id=2629495540","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629495540?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:32","pubTimestamp":1776861142,"startTime":"0","endTime":"0","summary":"VistaGen received an FDA “Study May Proceed” letter under its IND for refisolone nasal spray, clearing further Phase 2 development in US for menopausal hot flashes.Phase 2a data cited hot flash frequency fell 80% with refisolone versus 36% with placebo in a 36-patient study.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL9Sgs5y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629493680","title":"Vistagen Receives FDA “Study May Proceed” Letter Under Its Refisolone Ind Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) Due to Menopause","url":"https://stock-news.laohu8.com/highlight/detail?id=2629493680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629493680?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:30","pubTimestamp":1776861001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6HL0BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629049334","title":"Vistagen Therapeutics Inc - FDA Letter Enables Further Phase 2 Development of Refisolone in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629049334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629049334?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:30","pubTimestamp":1776861001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUA6HL0BN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627469666","title":"VistaGen Therapeutics Grants Broad Employee Retention Stock Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2627469666","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627469666?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:50","pubTimestamp":1776117000,"startTime":"0","endTime":"0","summary":"An announcement from VistaGen Therapeutics ( ($VTGN) ) is now available. On April 7, 2026, Vistagen Therapeutics’ compensation committee approved b...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-grants-broad-employee-retention-stock-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vistagen-therapeutics-grants-broad-employee-retention-stock-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VTGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627781466","title":"VistaGen grants retention stock options to executives at $0.54 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2627781466","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627781466?lang=en_us&edition=fundamental","pubTime":"2026-04-14 05:28","pubTimestamp":1776115711,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics set retention stock option awards for all employees on April 7, 2026.Each of five named executives received options for up to 75,000 shares.Options carry exercise price of $0.54 per share.Vesting starts with 25% at six months from grant date.Remaining vesting occurs in 25% installments every six months, reaching full vesting at two years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL8lwRpn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624509682","title":"VistaGen flags Nasdaq noncompliance after audit committee falls below three members","url":"https://stock-news.laohu8.com/highlight/detail?id=2624509682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624509682?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:18","pubTimestamp":1775161108,"startTime":"0","endTime":"0","summary":"VistaGen notified Nasdaq on April 1, 2026, that it is out of compliance with listing rule requiring at least three independent audit committee members.Nasdaq listing of VistaGen common stock remains unchanged while company uses cure period to regain compliance.Board plans to restore compliance before cure period expires.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VistaGen Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL6Cbh8c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VTGN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":80,"code":"91000000","status":"200"}]}}